1. Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use. (31st December 2022) Authors: Proudman, David; DeVito, Nicholas C.; Belinson, Suzanne; Allo, Mina Alsaraf; Morris, Eric D.; Signorovitch, James; Patel, Anuj K. Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib. (7th October 2019) Authors: Patel, Anuj K.; Barghout, Victoria; Yenikomshian, Mihran A.; Germain, Guillaume; Jacques, Philippe; Laliberté, François; Duh, Mei S. Journal: Oncologist Issue: Volume 25:Number 1(2020) Page Start: e75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center. (1st October 2021) Authors: Patel, Anuj K.; Abhyankar, Ritika; Brais, Lauren K.; Duh, Mei Sheng; Barghout, Victoria E.; Huynh, Lynn; Yenikomshian, Mihran A.; Ng, Kimmie; Fuchs, Charles S. Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: e2161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗